FREEPORT-MCMORAN ($FCX) is expected to release its quarterly earnings data on Thursday, October 23rd before market open, per Finnhub. Analysts are expecting revenue of $6,779,784,580 and earnings of $0.41 per share.
You can see Quiver Quantitative's $FCX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
FREEPORT-MCMORAN Insider Trading Activity
FREEPORT-MCMORAN insiders have traded $FCX stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $FCX stock by insiders over the last 6 months:
- ELLIE L. MIKES (Chief Accounting Officer) sold 8,584 shares for an estimated $343,519
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
FREEPORT-MCMORAN Hedge Fund Activity
We have seen 764 institutional investors add shares of FREEPORT-MCMORAN stock to their portfolio, and 661 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AMUNDI removed 22,749,581 shares (-82.3%) from their portfolio in Q2 2025, for an estimated $986,194,336
- VICTORY CAPITAL MANAGEMENT INC added 18,953,874 shares (+3404.6%) to their portfolio in Q2 2025, for an estimated $821,650,437
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 8,292,873 shares (+89.4%) to their portfolio in Q2 2025, for an estimated $359,496,044
- D. E. SHAW & CO., INC. removed 4,890,848 shares (-71.0%) from their portfolio in Q2 2025, for an estimated $212,018,260
- CITADEL ADVISORS LLC added 4,132,119 shares (+184.0%) to their portfolio in Q2 2025, for an estimated $179,127,358
- MIZUHO MARKETS CAYMAN LP added 3,671,219 shares (+inf%) to their portfolio in Q2 2025, for an estimated $159,147,343
- MIZUHO MARKETS AMERICAS LLC removed 3,605,634 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $156,304,233
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
FREEPORT-MCMORAN Congressional Stock Trading
Members of Congress have traded $FCX stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $FCX stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 08/13.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
FREEPORT-MCMORAN Analyst Ratings
Wall Street analysts have issued reports on $FCX in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 10/08/2025
- Wells Fargo issued a "Overweight" rating on 10/08/2025
- Morgan Stanley issued a "Overweight" rating on 10/08/2025
- UBS issued a "Buy" rating on 10/03/2025
- B of A Securities issued a "Buy" rating on 09/30/2025
- Raymond James issued a "Outperform" rating on 09/25/2025
- JP Morgan issued a "Overweight" rating on 09/25/2025
To track analyst ratings and price targets for FREEPORT-MCMORAN, check out Quiver Quantitative's $FCX forecast page.
FREEPORT-MCMORAN Price Targets
Multiple analysts have issued price targets for $FCX recently. We have seen 14 analysts offer price targets for $FCX in the last 6 months, with a median target of $48.0.
Here are some recent targets:
- Jonathan Brandt from HSBC set a target price of $50.0 on 10/17/2025
- Bill Peterson from JP Morgan set a target price of $50.0 on 10/09/2025
- Timna Tanners from Wells Fargo set a target price of $47.0 on 10/08/2025
- Alexander Hacking from Citigroup set a target price of $48.0 on 10/08/2025
- Carlos De Alba from Morgan Stanley set a target price of $46.0 on 10/08/2025
- Daniel Major from UBS set a target price of $48.0 on 10/03/2025
- Sam Crittenden from RBC Capital set a target price of $48.0 on 10/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
